Literature DB >> 16628530

Behavioral approaches to the treatment of migraine.

Kenneth A Holroyd1, Jana B Drew.   

Abstract

Behavioral interventions such as biofeedback training, relaxation training, and cognitive-behavior stress management therapy have been identified as efficacious treatments for migraine headache. These treatments, and the formats (clinic-based, limited-contact, and home-based) in which they are taught, are described in this article. Information about public health interventions (school, work, Internet, and mass media) is also briefly addressed. Results of studies examining the efficacy of behavioral treatments, how behavioral treatments compare in effectiveness, and how they can be integrated with pharmacotherapy are reviewed for both adult and pediatric populations. Finally, the role of behavioral treatments in migraine treatment guidelines is discussed, and factors that are associated with response to behavioral treatments are reviewed.

Entities:  

Mesh:

Year:  2006        PMID: 16628530     DOI: 10.1055/s-2006-939920

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

Review 1.  [Psychological therapy of migraine: systematic review].

Authors:  G Fritsche; B Kröner-Herwig; P Kropp; U Niederberger; G Haag
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

Review 2.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

3.  MIPAS-Family-evaluation of a new multi-modal behavioral training program for pediatric headaches: clinical effects and the impact on quality of life.

Authors:  Wolf-Dieter Gerber; Franz Petermann; Gabriele Gerber-von Müller; Maren Dollwet; Stephanie Darabaneanu; Uwe Niederberger; Ilva Elena Schulte; Ulrich Stephani; Frank Andrasik
Journal:  J Headache Pain       Date:  2010-04-08       Impact factor: 7.277

4.  A randomized trial of a web-based intervention to improve migraine self-management and coping.

Authors:  Jonas Bromberg; Mollie E Wood; Ryan A Black; Daniel A Surette; Kevin L Zacharoff; Emil J Chiauzzi
Journal:  Headache       Date:  2012-02       Impact factor: 5.887

5.  Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Authors:  Kenneth A Holroyd; Constance K Cottrell; Francis J O'Donnell; Gary E Cordingley; Jana B Drew; Bruce W Carlson; Lina Himawan
Journal:  BMJ       Date:  2010-09-29

Review 6.  Similarities and Differences Between Migraine in Children and Adults: Presentation, Disability, and Response to Treatment.

Authors:  Ashley M Kroon Van Diest; Michelle M Ernst; Shalonda Slater; Scott W Powers
Journal:  Curr Pain Headache Rep       Date:  2017-10-25

7.  What Factors Contribute to Headache-Related Disability in Teens?

Authors:  Kathi J Kemper; Geoffrey Heyer; Ann Pakalnis; Philip F Binkley
Journal:  Pediatr Neurol       Date:  2015-12-24       Impact factor: 3.372

8.  Are migraine and tension-type headache diagnostic types or points on a severity continuum? An exploration of the latent taxometric structure of headache.

Authors:  Dana P Turner; Todd A Smitherman; Anna Katherine Black; Donald B Penzien; John A H Porter; Kenneth R Lofland; Timothy T Houle
Journal:  Pain       Date:  2015-07       Impact factor: 7.926

9.  Multimodal behavioral treatment of migraine: an Internet-administered, randomized, controlled trial.

Authors:  Kerstin Hedborg; Carin Muhr
Journal:  Ups J Med Sci       Date:  2011-04-20       Impact factor: 2.384

Review 10.  Assessing and treating primary headaches and cranio-facial pain in patients undergoing rehabilitation for neurological diseases.

Authors:  Cristina Tassorelli; Marco Tramontano; Mariangela Berlangieri; Vittorio Schweiger; Mariagrazia D'Ippolito; Valerio Palmerini; Sara Bonazza; Riccardo Rosa; Rosanna Cerbo; Maria Gabriella Buzzi
Journal:  J Headache Pain       Date:  2017-09-29       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.